| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00052715 Details | 2018-07-18 Interventional | 2 | [1 Refs] | 31 | Poly ICLC Central Nervous… Glioblastoma Nervous System … Brain and Centr… | prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly
diagnosed GMB pts as RT plus concomitant and adjuvant TMZ Enrollment was prematurely discontinued after the results of the EORTC phase-3 study defined the standard of care for newly diagnosed glioblastoma patients as radiotherapy plus concomitant and adjuvant temozolomide (2005) | ||
| NCT03343977 Details | 2018-07-17 Interventional | 1/2 | 0 | Docetaxel Hypersensitivit… Prostatic Neopl… Metastatic Horm… | Study withdrawn for technical reasons - | |||
| NCT02629094 Details | 2018-07-17 Interventional | 2 | [1 Refs] | 5 | Eplerenone Fatty Liver HIV Infections Cardiac Steatos… Hepatic Steatos… | - - | ||
| NCT01006252 Details | 2018-07-17 Interventional | 3 | 336 | Paclitaxel Melanoma | More possibly treatment-related deaths on tasisulam-sodium arm. - | |||
| NCT02796547 Details | 2018-07-13 Interventional | 2 | 0 | Levobupivacaine Episiotomy | Lack of human ressources - | |||
| NCT02345460 Details | 2018-07-13 Interventional | 2 | 1 | Calcium Fluorouracil Irinotecan Leucovorin Levoleucovorin Oxaliplatin Adenocarcinoma Neoplasms Pancreatic Neop… Pancreatic Aden… Poorly Differen… Resectable Panc… Stage IA Pancre… Stage IB Pancre… Stage IIA Pancr… Stage IIB Pancr… Stage III Pancr… Undifferentiate… | Competing studies - | |||
| NCT01921751 Details | 2018-07-13 Interventional | 2 | 20 | Albumin-Bound P… Capecitabine Gemcitabine Paclitaxel Pancreatic Neop… Pancreatic Aden… Stage III Pancr… | Trial would not be completed in a reasonable timeframe per CTEP guidelines This study terminated early with only 20 registered (346 planned) and 13 randomized (288 planned). Follow-up forms were collected on only 3 patients. | |||
| NCT02069080 Details | 2018-07-12 Interventional | 1 | 2 | Plerixafor Cancer | - - | |||
| NCT00386399 Details | 2018-07-12 Interventional | 2 | 0 | Mitomycin Mitomycins Pancreatic Neop… Pancreatic Canc… | All consented subjects tested negative for the BRCA2 mutation, therefore, did not meet criteria
to start the study, resulting in withdrawal by PI - | |||
| NCT00268450 Details | 2018-07-12 Interventional | 2 | 21 | Bevacizumab Gemcitabine Paclitaxel Urinary Bladder… Bladder Cancer | - - | |||
| NCT01975376 2013-002646-36 Details | 2018-07-11 Interventional | 3 | 16784 | Bococizumab Cardiovascular … Cardiovascular … | See Detailed Description As specified in statistical analysis plan, due to discontinuation of the bococizumab clinical development program, health care resource utilization endpoints were not evaluated. | |||
| NCT02767752 Details | 2018-07-10 Interventional | 2 | 21 | Capecitabine Gemcitabine Pancreatic Neop… Pancreatic Canc… | Poor accrual and change of SOC (FOLFIRINOX in adjuvant setting) - | |||
| NCT02724150 Details | 2018-07-10 Interventional | 4 | 0 | Omeprazole Hemorrhage Peptic Ulcer Peptic Ulcer He… Ulcer Gastroduodenal … Marginal Ulcer | No participants enrolled - | |||
| NCT02479204 Details | 2018-07-10 Interventional | 1 | 10 | Atenolol Diltiazem Healthy Subject… | Based on results from the pilot phase, the study is terminated. No safety events leading to
discontinuation were reported - | |||
| NCT00646659 2006-004189-14 Details | 2018-07-09 Interventional | 2 | 47 | Carboplatin Cetuximab Docetaxel Fluorouracil Head and Neck N… Head and Neck C… | Recruitment was suspended prematurely for safety concerns and closed after IDMC review - | |||
| NCT00458276 Details | 2018-07-09 Interventional | 3 | 274 | Tezosentan Heart Diseases Hypertension Hypertension, P… | 6 month vital status report not collected after 28 day follow up analysis indicated no
difference between placebo & tezosentan - | |||
| NCT00302731 Details | 2018-07-06 Interventional | 2 | 21 | Estradiol Estradiol 17 be… Estradiol 3-ben… Estrogens Hormones Polyestradiol p… Progesterone Menopause | - - | |||
| NCT02014545 Details | 2018-07-05 Interventional | 2 | 0 | Lucanthone Brain Neoplasms Carcinoma, Non-… Lung Neoplasms Neoplasm Metast… Brain Metastase… Non-small Cell … | Pending resolution of study drug issues - | |||
| NCT01910428 Details | 2018-07-05 Interventional | 1 | 14 | Asparaginase Eryaspase Leukemia Leukemia, Lymph… Lymphoma Precursor Cell … Acute Lymphobla… Lymphoblastic L… | Sponsor decision based off site/PI feedback about - | |||
| NCT01814059 Details | 2018-07-05 Interventional | 1 | 4 | Sirolimus Digestive Syste… Eosinophilic Es… Esophagitis Gastroenteritis Gastrointestina… Eosinophilic Ga… | - - |